Administrative Core
Administrative Core
批准号:
10592409
负责人:
Frances E. Lund
金额:
$9.93万
依托单位国家:
美国
项目类别:
财政年份:
2019
资助国家:
美国
项目状态:
未结题
起止时间:
2019-04-01 至 2025-03-31
关键词:
AccountingAdaptive Immune SystemAntibodiesAntigen PresentationAsthmaAuthorization documentationAutoimmunityB-LymphocytesBloodBudgetsCD4 Positive T LymphocytesCardiovascular DiseasesCell FractionCell LineageCell TransplantationCellsCellular biologyCollaborationsCollectionCommunicationDataDedicationsDiabetes MellitusEffector CellElephantsEnsureEventExpenditureFeedbackFinancial SupportFosteringFutureGoalsGraft RejectionGrantGuidelinesHealthHealth Care CostsHeterogeneityHost DefenseHumanHuman ResourcesImmuneImmune systemImmunityImmunologyIndividualInfectionInstitutionInvestigationInvestmentsLearningMediatingMedicineMemoryMemory B-LymphocyteMolecularMonitorMorbidity - disease rateMusOrganParticipantPathologicPlasma CellsPlayPoliciesProductionProgress ReportsPropertyRegulationReportingResearchResearch PersonnelResearch Project GrantsResearch SupportRoleRotationScheduleScientistServicesStudy modelsTailTimeTissuesTransplantationTravelUnited States National Institutes of HealthUniversitiesVisitWorkarmauthoritychemokinechronic inflammatory diseasecytokinehuman tissueimmune functioninsightinterestlecturermeetingsmembermortalitymouse modelpathogenic bacteriapathogenic virusprogramsresponsescientific organizationsuccesssymposiumtissue injurytissue repairtumor-immune system interactions
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Core A: Administrative Core
Project Summary
The immune system plays a critical role in protecting us from infection and resolving or repairing tissue injury
following infection or other environmental insults that cause damage. The immune system is also a major
contributor to chronic inflammatory diseases that drive health care costs and morbidity and mortality in the
U.S., including cardiovascular disease, diabetes, autoimmunity, asthma, transplant rejection and many others.
Over the last three decades we have learned much about how immune cells develop and mature, how immune
cells are activated and differentiate into “effector” cells, how immune cell memory is initiated and maintained
and how immune cells contribute in a functional way to immune-mediated protection and damage. In this U19
Program, we are particularly interested in B lineage cells that contribute to immune function by presenting
antigen and activating CD4 T cells, by altering the immune microenvironment through the production of
cytokines and chemokines and, most importantly, by differentiating into short- and long-lived antibody
producing plasma cells (ASCs) and long-lived memory B cells. These cells are responsible for the humoral arm
of the adaptive immune system and are key to host defense against most viral and bacterial pathogens.
However, antibodies produced by ASCs are also responsible for much of the tissue damage associated with
autoimmunity, asthma and transplantation. Many of our insights into the protective and pathologic functions of
B lymphocytes and ASCs have come from genetically modified mouse model studies and, although these
studies have been very informative, it is clear that mice and humans are not identical and that there is a need
to better understand how human B cells contribute to immune (dys)function. Our studies of human B cells are
still quite rudimentary – largely because the studies have been limited to the easily accessible circulating blood
compartment. This is the equivalent of studying the tail of the elephant without seeing the whole elephant – we
miss most of the complexity and heterogeneity of B cells when we only examine a tiny fraction of the cells that
are present in the body. In this U19, we plan to move beyond the elephant tail as our goal is to
comprehensively examine the molecular, cellular and functional properties of human B cells that reside
specifically in the less accessible human tissues and organs. The major objective of Core A is to provide
oversight and support for the overall Program and the individual projects and cores. We will meet this objective
by: (i) providing all projects and cores with scientific, administrative, regulatory and financial oversight; and (ii)
organizing scientific interactions, including the monthly research in progress meetings for the Program
scientists, the annual retreat with the scientific advisory board, the annual meeting with other Cooperative
Centers on Human Immunology groups and the Human Immunology themed session at the Southeastern
Immunology Symposium. Through these activities, Core A will ensure the overall success of the Program.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
TLR7 and TLR9-directed plasma cell formation: Dissecting the molecular basis for their differential dependence on IFN-induced signals
-
批准号:10642784
-
项目类别:
-
资助金额:$71.33万
-
财政年份:2020
-
负责人:Frances E. Lund
-
依托单位:
TLR7 and TLR9-directed plasma cell formation: Dissecting the molecular basis for their differential dependence on IFN-induced signals
-
批准号:10431929
-
项目类别:
-
资助金额:$71.33万
-
财政年份:2020
-
负责人:Frances E. Lund
-
依托单位:
Tissue and organ specific human B cell immunity
-
批准号:10265689
-
项目类别:
-
资助金额:$44.49万
-
财政年份:2020
-
负责人:Frances E. Lund
-
依托单位:
TLR7 and TLR9-directed plasma cell formation: Dissecting the molecular basis for their differential dependence on IFN-induced signals
-
批准号:10032785
-
项目类别:
-
资助金额:$72.54万
-
财政年份:2020
-
负责人:Frances E. Lund
-
依托单位:
Identification and characterization of effector memory B cell populations that dominate memory responses to subsequent influenza infection and vaccination
-
批准号:10227903
-
项目类别:
-
资助金额:$73.54万
-
财政年份:2020
-
负责人:Frances E. Lund
-
依托单位:
TLR7 and TLR9-directed plasma cell formation: Dissecting the molecular basis for their differential dependence on IFN-induced signals
-
批准号:10214491
-
项目类别:
-
资助金额:$71.33万
-
财政年份:2020
-
负责人:Frances E. Lund
-
依托单位:
Identification and characterization of effector memory B cell populations that dominate memory responses to subsequent influenza infection and vaccination
-
批准号:10455632
-
项目类别:
-
资助金额:$73.54万
-
财政年份:2020
-
负责人:Frances E. Lund
-
依托单位:
Administrative Core
-
批准号:10395996
-
项目类别:
-
资助金额:$44.45万
-
财政年份:2019
-
负责人:Frances E. Lund
-
依托单位:
Characterization of virus-specific human B cell subsets in lymphoid and non-lymphoid tissues
-
批准号:10592418
-
项目类别:
-
资助金额:$94.58万
-
财政年份:2019
-
负责人:Frances E. Lund
-
依托单位:
Tissue and organ specific human B cell immunity
-
批准号:10592408
-
项目类别:
-
资助金额:$355.3万
-
财政年份:2019
-
负责人:Frances E. Lund
-
依托单位:
Infrastructure and Opportunity Fund Management Core
-
批准号:10592414
-
项目类别:
-
资助金额:$145.47万
-
财政年份:2019
-
负责人:Frances E. Lund
-
依托单位:
Characterization of virus-specific human B cell subsets in lymphoid and non-lymphoid tissues
-
批准号:10396002
-
项目类别:
-
资助金额:$44.45万
-
财政年份:2019
-
负责人:Frances E. Lund
-
依托单位:
Tissue and organ specific human B cell immunity
-
批准号:10395994
-
项目类别:
-
资助金额:$355.62万
-
财政年份:2019
-
负责人:Frances E. Lund
-
依托单位:
Infrastructure and Opportunity Fund Management Core
-
批准号:10396000
-
项目类别:
-
资助金额:$44.45万
-
财政年份:2019
-
负责人:Frances E. Lund
-
依托单位:
Control of anti-viral B cell responses by IFNg, T-bet and Eomes
-
批准号:8806524
-
项目类别:
-
资助金额:$21.45万
-
财政年份:2014
-
负责人:Frances E. Lund
-
依托单位:
Control of B cell differentiation by IFNg induced transcription factors
-
批准号:10307593
-
项目类别:
-
资助金额:$26.0万
-
财政年份:2014
-
负责人:Frances E. Lund
-
依托单位:
Control of B cell differentiation by IFNg induced transcription factors
-
批准号:10521294
-
项目类别:
-
资助金额:$26.0万
-
财政年份:2014
-
负责人:Frances E. Lund
-
依托单位:
Control of anti-viral B cell responses by IFNg, T-bet and Eomes
-
批准号:8992350
-
项目类别:
-
资助金额:$21.45万
-
财政年份:2014
-
负责人:Frances E. Lund
-
依托单位:
Control of anti-viral B cell responses by IFNg, T-bet and Eomes
-
批准号:9204378
-
项目类别:
-
资助金额:$21.45万
-
财政年份:2014
-
负责人:Frances E. Lund
-
依托单位:
Control of B cell differentiation by IFNg induced transcription factors
-
批准号:9887750
-
项目类别:
-
资助金额:$26.0万
-
财政年份:2014
-
负责人:Frances E. Lund
-
依托单位:
海外基金